SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-15-318489
Filing Date
2015-09-11
Accepted
2015-09-11 16:16:00
Documents
1
Group Members
ANNE-MARI PASTEROMEGA FUND IV G.P. MANAGER, LTD.OMEGA FUND IV GP, L.P.OMEGA FUND IV, L.P.OTELLO STAMPACCHIARICHARD LIM

Document Format Files

Seq Description Document Type Size
1 0001583648 d90294dsc13g.htm SC 13G 138589
  Complete submission text file 0001193125-15-318489.txt   140646
Mailing Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354
Business Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354 49 81 6114 11400
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88917 | Film No.: 151103529
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O AMICORP LUXEMBOURG S.A. 11-13, BOULEVARD DE LA FOIRE GRAND DUCHY OF LUXEMBOURG N4 L-1528
Business Address C/O AMICORP LUXEMBOURG S.A. 11-13, BOULEVARD DE LA FOIRE GRAND DUCHY OF LUXEMBOURG N4 L-1528 352 2627 43 1
Global Life Bioventure IV S.a.r.l. (Filed by) CIK: 0001652769 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G